Federated Hermes
BMY icon

Federated Hermes’s Bristol-Myers Squibb BMY Stock Holding History

Federated Hermes’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-40,000
Closed -$2.28M – 2126
2016
Q4 		$2.28M Buy
+40,000
New +$2.19M 0.01% 817

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Federated Hermes's BMY Position: Q1 2026 in Review

Federated Hermes reduced its Bristol-Myers Squibb (BMY) stake by 6.5% in Q1 2026, selling an estimated $141K and leaving 34,632 shares worth $2.1M. The position accounts for ﹤0.01% of the portfolio, ranked #966.

Federated Hermes first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $505M in Q4 2024. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Federated Hermes held 34,632 shares of Bristol-Myers Squibb worth $2.1M as of Q1 2026.
  • Federated Hermes sold 2,412 Bristol-Myers Squibb shares in Q1 2026, an estimated $141K.
  • Bristol-Myers Squibb made up ﹤0.01% of Federated Hermes's portfolio in Q1 2026, its #966 holding.
  • Federated Hermes first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
  • Federated Hermes's Bristol-Myers Squibb position peaked at $505M in Q4 2024.
  • 2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Federated Hermes's 13F filing for Q1 2026, filed 11 May 2026.